Postdischarge Opioid Use after Lower Extremity Bypass Surgery

Abstract

Opioid overprescription for acute postoperative pain is an inadvertent contributor to the opioid epidemic via pill diversion and misuse. In response, the surgical community advocates for evidence-based postoperative opioid prescribing guidelines. The objective of this study is to evaluate patient-reported opioid consumption after lower extremity bypass surgery. We conducted a retrospective review of a prospectively maintained database of infrainguinal bypass operations from 2016 to 2019. For patients receiving an opioid prescription at discharge, a telephone survey was administered questioning the percentage of pills used. Exclusion criteria included chronic opioid use and reoperations or amputations within 30days. The primary outcome was the difference in opioids prescribed versus opioids consumed. Forty-nine patients met inclusion criteria. Forty-one (84%) were prescribed opioids at discharge, and 27 (65.9%) completed the survey. The average age was 65.8±7.7years; 29.6% were women. Oxycodone immediate-release was most commonly prescribed (78%). On average, patients received 318±156 morphine milligram equivalent. A total of 940 opioid pills were prescribed (36.0±11.3 per patient), but only 37% were consumed. This difference resulted in 568 unused pills. This is the first study to specifically evaluate opioid use in a strictly lower extremity bypass population. Over 60% of pills were unused, which poses significant societal risk for misuse. Our findings contribute to knowledge of operation-specific opioid use, which may shape practice recommendations and reduce opioid overprescription after vascular surgery.